Quick Summary:
In the ever-evolving landscape of pain management therapies, the Non-opioid Pain Patches Market represents a significant segment underscored by a patient-centric approach to alleviate discomfort without the risks associated with opioid medications. This meticulously crafted market research report is a must-have for senior executives exploring robust investment opportunities within this niche.
The report provides a roadmap to navigate the complexity of the market dynamics, offering deep insights into the competitive landscape, varying consumer preferences, and regulatory implications. It analyzes the market’s wide array of patch types, indications, and distribution channels, delivering a strategic edge to stakeholders in positioning their products effectively. With a thorough evaluation of market share and positioning, complemented by comprehensive profiles of key players, this report equips decision-makers with the intelligence required to capitalize on market trends and optimize growth potential.
1h Free Analyst Time
The Non-opioid Pain Patches Market size was estimated at USD 622.13 million in 2022, USD 701.29 million in 2023, growing at a CAGR of 12.86% to reach USD 1,637.77 million by 2030. Speak directly to the analyst to clarify any post sales queries you may have.
Market Segmentation & Coverage:
This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Non-opioid Pain Patches Market.- Based on Patch Type, the market is studied across Capsaicin Patches, Diclofenac Patches, Ketoprofen Patches, Lidocaine Patches, and Methyl Salicylate Patches. The Methyl Salicylate Patches is projected to witness significant market share during forecast period.
- Based on Indication, the market is studied across Arthritis, Back Pain, Fibromyalgia, Migraines & Headaches, Muscle Strain & Sprains, and Post-Herpetic Neuralgia. The Muscle Strain & Sprains is projected to witness significant market share during forecast period.
- Based on Distribution, the market is studied across Drug Stores, Hospitals, and Online Pharmacies. The Hospitals is projected to witness significant market share during forecast period.
- Based on Region, the market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. Europe, Middle East & Africa is is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 38.74% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:
The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.FPNV Positioning Matrix:
The FPNV Positioning Matrix is an indispensable tool for assessing the Non-opioid Pain Patches Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.Market Share Analysis:
The Market Share Analysis offers invaluable insights into the vendor landscape Non-opioid Pain Patches Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.Key Company Profiles:
The report delves into recent significant developments in the Non-opioid Pain Patches Market, highlighting leading vendors and their innovative profiles. These include Bridges Consumer Healthcare, LLC, Cardinal Health, Inc., Endo International plc, GlaxoSmithKline Plc., Hisamitsu Pharmaceutical Co., Inc., Johnson & Johnson Services, Inc., Pfizer Inc., Sanofi S.A., SCILEX Pharmaceuticals Inc., Sorrento Therapeutics, Inc., Teh Seng Pharmaceutical Mfg. Co., Ltd., Teikoku Seiyaku Co. Ltd., Teva Pharmaceutical Industries Ltd., Veridian Healthcare, and Virpax Pharmaceuticals, Inc.The report offers valuable insights on the following aspects:
- Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
- Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
- Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
- Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
- Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
- What is the market size and forecast for the Non-opioid Pain Patches Market?
- Which products, segments, applications, and areas hold the highest investment potential in the Non-opioid Pain Patches Market?
- What is the competitive strategic window for identifying opportunities in the Non-opioid Pain Patches Market?
- What are the latest technology trends and regulatory frameworks in the Non-opioid Pain Patches Market?
- What is the market share of the leading vendors in the Non-opioid Pain Patches Market?
- Which modes and strategic moves are suitable for entering the Non-opioid Pain Patches Market?
Please note: For this report, the purchase of an Enterprise license allows up to ten worldwide users of an organization access to the report
Please note: This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.
Frequently Asked Questions about the Global Non-opioid Pain Patches Market
What is the estimated value of the Global Non-opioid Pain Patches Market?
What is the growth rate of the Global Non-opioid Pain Patches Market?
What is the forecasted size of the Global Non-opioid Pain Patches Market?
Who are the key companies in the Global Non-opioid Pain Patches Market?
| Report Attribute | Details |
|---|---|
| No. of Pages | 196 |
| Published | October 2023 |
| Forecast Period | 2023 - 2030 |
| Estimated Market Value ( USD | $ 701.29 Million |
| Forecasted Market Value ( USD | $ 1637.77 Million |
| Compound Annual Growth Rate | 12.8% |
| Regions Covered | Global |
| No. of Companies Mentioned | 15 |
Table of Contents
1. Preface
2. Research Methodology
4. Market Overview
5. Market Insights
6. Non-opioid Pain Patches Market, by Patch Type
7. Non-opioid Pain Patches Market, by Indication
8. Non-opioid Pain Patches Market, by Distribution
9. Americas Non-opioid Pain Patches Market
10. Asia-Pacific Non-opioid Pain Patches Market
11. Europe, Middle East & Africa Non-opioid Pain Patches Market
12. Competitive Landscape
13. Competitive Portfolio
14. Appendix
List of Figures
List of Tables
Companies Mentioned
- Bridges Consumer Healthcare, LLC
- Cardinal Health, Inc.
- Endo International plc
- GlaxoSmithKline Plc.
- Hisamitsu Pharmaceutical Co., Inc.
- Johnson & Johnson Services, Inc.
- Pfizer Inc.
- Sanofi S.A.
- SCILEX Pharmaceuticals Inc.
- Sorrento Therapeutics, Inc.
- Teh Seng Pharmaceutical Mfg. Co., Ltd.
- Teikoku Seiyaku Co. Ltd.
- Teva Pharmaceutical Industries Ltd.
- Veridian Healthcare
- Virpax Pharmaceuticals, Inc.
Methodology
LOADING...
